Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 181

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Racial, Social, and Clinical Determinants of Hepatocellular Carcinoma Surveillance

Open access
Singal, Amit G., Li, Xilong, Tiro, Jasmin, Kandunoori, Pragathi, Adams-Huet, Beverley, Nehra, Mahendra S., Yopp, Adam · 2015 · The American Journal of Medicine

Abstract

Background Fewer than 1 in 5 patients receive hepatocellular carcinoma surveillance; however, most studies were performed in racially and socioeconomically homogenous populations and few used guideline-based definitions for surveillance. Aims To characterize guideline-consistent hepatocellular carcinoma surveillance rates and identify determinants of hepatocellular carcinoma surveillance among a racially and socioeconomically diverse cohort of cirrhotic patients. Methods We retrospectively characterized hepatocellular carcinoma surveillance among cirrhotic patients followed between July 2008 and July 2011 at an urban safety-net hospital. Inconsistent surveillance was defined as at least one screening ultrasound during the 3-year period, annual surveillance as screening ultrasounds every 12 months, and biannual surveillance as screening ultrasounds every 6 months. Univariate and multivariate analyses were conducted to identify predictors of surveillance. Results Of 904 cirrhotic patients, 603 (67%) underwent inconsistent surveillance. Failure to recognize cirrhosis was a significant barrier to surveillance utilization (p<0.001). Inconsistent surveillance was associated with insurance status (OR 1.43, 95%CI 1.03–1.98), multiple primary care visits per year (OR 2.63, 95%CI 1.86–3.71), multiple hepatology visits per year (OR 3.75, 95%CI 2.64–5.33), African American race (OR 0.61, 95%CI 0.42–0.99), nonalcoholic steatohepatitis etiology (OR 0.60, 95%CI 0.37–0.98), and extrahepatic cancer (OR 0.43, 95%CI 0.24–0.77). Only 98 (13.4%) of 730 patients underwent annual surveillance, and only 13 (1.7%) of 786 had biannual surveillance. Conclusions Only 13% of patients with cirrhosis receive annual surveillance and less than 2% receive biannual surveillance. There are racial and socioeconomic disparities, with lower rates of hepatocellular carcinoma surveillance among African Americans and underinsured patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.amjmed.2014.07.027

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 181

Metadata

Authors
Singal, A. G., Li, X., Tiro, J., Kandunoori, P., Adams-Huet, B., Nehra, M. S., & Yopp, A.
Venue
The American Journal of Medicine
Publisher
Elsevier BV
Published
2015-01
Volume
128
Issue
1
Pages
90.e1-90.e7
ISSN
0002-9343 (ISSN-L)
OpenAlex
W2028980317
Cited by
181
References
3
FWCI
6.72
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Racial, Social, and Clinical Determinants of Hepatocellular Carcinoma Surveillance. https://app.cochat.ai/papers/10.1016/j.amjmed.2014.07.027
The paper
Singal, A. G., Li, X., Tiro, J., Kandunoori, P., Adams-Huet, B., Nehra, M. S., & Yopp, A. (2015). Racial, Social, and Clinical Determinants of Hepatocellular Carcinoma Surveillance. The American Journal of Medicine. https://doi.org/10.1016/j.amjmed.2014.07.027

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.